Companies
Olipop
Poppi's closest prebiotic-soda rival, now a fixture alongside Poppi on Whole Foods and Target shelves, marketed on prebiotics, fiber and botanicals.
- Country
- United States
Coverage
| EU | IN | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfda
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $50 million Series C funding round in February 2025, with total funding approximately $243 million across five rounds | femfounded.org · cnbc.com · fooddive.com |
| Certification | B Corp certified (score: 91) | femfounded.org · healthrx.com |
| Regulatory approval | Products are FDA-regulated conventional foods; co-manufacturing partners hold active FDA food facility registrations | healthrx.com |
| Production site | Olipop operates via a network of third-party co-manufacturers rather than owning its own production sites | meterwork.com · startup.jobs |
| Headcount | 449 employees as of July 27, 2026 | tipranks.com |
| Revenue | $400 million in 2024; projected to reach roughly $500 million in 2025 | femfounded.org · cnbc.com · fooddive.com |
Independent sources: cnbc.com · femfounded.org · fooddive.com · healthrx.com · meterwork.com · startup.jobs · tipranks.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio-nutraceutical drinks and functional beverages | food-alt-protein | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.